Literature DB >> 9036941

Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion.

G E Sonenshein1.   

Abstract

Whereas overexpression of the c-myc gene was found to promote apoptosis in fibroblasts, myeloid, and T cells, physiologic cell death of immature B cell lymphomas correlated with a drop in c-myc expression. Here, the author reviews recent evidence demonstrating that inhibition of c-myc expression activates apoptosis of B cell models of clonal deletion and that rescue from apoptosis by CD40 ligand leads to maintenance of c-Myc levels. A model of differential functional expression of the c-myc gene is discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9036941

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells.

Authors:  F Zhou; R D Medh; E B Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2000 Jul-Aug       Impact factor: 4.292

2.  c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells.

Authors:  Murali Gururajan; Roger Chui; Anbu K Karuppannan; Jiyuan Ke; C Darrell Jennings; Subbarao Bondada
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

3.  Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.

Authors:  Revathi Rajkumar; Kazuhisa Konishi; Thomas J Richards; David C Ishizawar; Andrew C Wiechert; Naftali Kaminski; Ferhaan Ahmad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-15       Impact factor: 4.733

4.  Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc.

Authors:  L Genestier; S Kasibhatla; T Brunner; D R Green
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

5.  Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells.

Authors:  M Wu; R E Bellas; J Shen; G E Sonenshein
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

6.  EndoU is a novel regulator of AICD during peripheral B cell selection.

Authors:  Jonathan C Poe; Evgueni I Kountikov; Jacquelyn M Lykken; Abirami Natarajan; Douglas A Marchuk; Thomas F Tedder
Journal:  J Exp Med       Date:  2013-12-16       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.